|
|
Home  About BioMarket
|
|
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.
Browse
Indian Biofuel Industry
This report provides research and objective analysis of Biofuels industry in India. This report helps clients to evaluate the current status and opportunities in the Indian Biofuels market.
Clinical Decision Support in Healthcare
An in-depth analysis of the CDS market including the drivers and inhibitors of CDS adoption, the types of tools available today as well as in the future, ways to effectively implement CDS and recommendations to vendors.
Stakeholder Insight: Renal Cancer
In the 7 major markets, Datamonitor estimates that the incidence of RCC in 2007 will total 86,800 cases. Around 25% of all RCC patients are diagnosed with Stage IV disease; the 2-year survival rate for these patients is around 23%. This low survival ra
The Global HIV/AIDS Market Outlook to 2012
This report analyses current leading brands of treatment within the HIV market, provides invaluable insights into market dynamics, profiles the leading pharmaceutical companies and details the key market trends influencing product sales.
Sandoz - PharmaVitae Generics Profile
This analysis examines the historical and forecast performance for Sandoz in the generic pharmaceutical sector. The profile encompasses global company strategy, generic and biosimilar portfolio and pipeline analysis and assessment of financial performa
The Top Ten Specialty Pharmaceutical Companies
This report explores the global competitive landscape of the specialty pharmaceutical industry. The latest key trends and evolving business models in the specialty pharmaceutical market are identified and the leading companies in this sector are profi
Cell Therapy Markets
The goal of this report is to review the market for cell therapy products using screening reagents and instruments for analysis of individual components in tissue samples, blood, serum or plasma.
Bristol-Myers Squibb Partnering Guide 2008
The Bristol-Myers Squibb Partnering Guide 2008 provides an in-depth insight into the dealmaking interests and activity of one of the worlds leading biopharma companies
Shire Partnering Guide 2008
The Shire Partnering Guide 2008 provides an in-depth insight into the dealmaking interests and activity of one of the worlds leading biopharma companies
Contract Pharma 2008-2023
This report evaluates the prospects for outsourcing manufacturing and other operations from pharmaceutical companies, especially off-shoring to developing nations such as China and India. Furthermore, this report analyses the increasing trend for Japan
C.R. Bard Inc: Premium Company Profile
C.R. Bard (Bard), which celebrated its centenary in 2007, is one of the leading global developer, manufacturer and marketer of medical technologies in the fields of vascular, urology, oncology and surgical specialty products. The company has pioneered
Indian Pharmaceutical Industry
The purpose of this study is to describe the specific segment of the pharmaceutical market sector called the Indian pharmaceutical industry.
Bladder Cancer Drug Pipeline Update 2008
There are today no less than 58 therapeutics targeting bladder cancer, from early preclinical to marketed drugs. Bladder Cancer Drug Pipeline Update lists all drugs and gives you a progress analysis on each one of them. Identified drugs are linked to 3
Commercial Insight: Antidyslipidemics
The restrictive, highly competitive antidyslipidemic market is going to become even further genericized, which will add to the challenges that drug makers are facing. Despite over 300m people being eligible for antidyslipidemic treatment, there is stil
| | |
